- “The singularity,” the moment where AI is no longer under human control, is less than a decade away—according to one AI expert.
- More resources than ever are being poured into the pursuit of artificial general intelligence and speeding the growth of AI.
- Development of AI is also coming from a variety of sectors, pushing the technology forward faster than ever before.
There’s at least one expert who believes that “the singularity”—the moment when artificial intelligence surpasses the control of humans—could be just a few years away. That’s a lot shorter than current predictions regarding the timeline of AI dominance, especially considering that AI dominance is not exactly guaranteed in the first place.
Ben Goertzel, CEO of SingularityNET—who holds a Ph.D. from Temple University and has worked as a leader of Humanity+ and the Artificial General Intelligence Society—toldDecrypt that he believes artificial general intelligence (AGI) is three to eight years away. AGI is the term for AI that can truly perform tasks just as well has humans, and it’s a prerequisite for the singularity soon following.
Whether you believe him or not, there’s no sign of the AI push slowing down any time soon. Large language models from the likes of Meta and OpenAI, along with the AGI focus of Elon Musk’s xAI, are all pushing hard towards growing AI.
“These systems have greatly increased the enthusiasm of the world for AGI,” Goertzel told Decrypt, “so you’ll have more resources, both money and just human energy—more smart young people want to plunge into work and working on AGI.”
When the concept of AI started first emerged—as early as the 1950s—Goertzel says that its development was driven by the United States military and seen primarily as a potential national defense tool. Recently, however, progress in the field has been propelled by a variety of drivers with a variety of motives. “Now the ‘why’ is making money for companies,” he says, “but also interestingly, for artists or musicians, it gives you cool tools to play with.”
Getting to the singularity, though, will require a significant leap from the current point of AI development. While today’s AI typically focuses on specific tasks, the push towards AGI is intended to give the technology a more human-like understanding of the world and open up its abilities. As AI continues to broaden its understanding, it steadily moves closer to AGI—which some say is just one step away from the singularity.
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
